Imclone systems (IMCL) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Imclone systems (IMCL)

IMCL 0.159

0.0%

Oct 5 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Raven McCloud who wrote (423)	3/15/1999 11:00:00 PM
From: CPAMarty	Read Replies (1) of 2515

I think you shorted too soon, my WAG is it will test $16 before it sees 11 again; if it does see $11 again. $12 to $16 is the range i see until additional analyst coverage or FDA approval of fast track or more peer review of IMCL's science occurs. If the volume holds up perhaps IMCL will attract some more institutional investors. at this point I don't see much up side for IMCL LOLOL oh, ok, then i guess that there is no reason to spend all that money on phase III trials (the German drug company must be run by idiots, right?)- after all we are only talking about a possible major advancement in treatment for cancer<G> Raven, you certainly have a lot of guts to short this one. I am one long that hopes that we have a huge short interest when the figures come out in about a week - it will make for a nice short squeeze later on.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next